Reversing oral anticoagulants with a focus on Andexanet Alfa
1:00:57
Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
1:04:13
Oct. 2024 PEP Talk: Anticoagulation and Reversal Agents
56:16
VTE and Movement
54:22
Dr. Thomas Seyfried: Cancer as a Mitochondrial Metabolic Disease
12:09
Oral Anticoagulants || Warfarin || Rivaroxaban || Apixiban || Dabigatran
20:59
Anticoagulant Reversal
19:03
DOACs Part 3: Anticoagulation Principles - Part 3: Pt Counseling / Management of DOAC Bleeding
58:43